Keywords: phase, ii, results, lilly, olanzapine, eli, new

Phase II Results With Lilly's Olanzapine

Article | 18 July 1994

Print This

Eli Lilly's new atypical antipsychotic agent olanzapine may prove to have efficacy in treating both the positive and negative symptoms ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in